Anika Therapeutics Inc

Biotech Stocks Healthcare Stocks

$14.63

-0.38 (-2.53%)

As of Jun 30, 10:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +63.9% upside

Low Target $18.55

Average Target $23.98

High Target $27.85

Current Price $14.63

Current
$14.63

Target
$23.98

$18.55 $23.98 avg $27.85

Scenario Analysis

Bear Case

$18.55

26.8%

Low target

Base Case

$23.98

+63.9%

Avg target

Bull Case

$27.85

+90.4%

High target

Risk/Reward

3.4x

Highly favorable

Price in Context

52-Week High

$16.24

-9.9% from high

52-Week Low

$7.87

+85.9% from low

Target vs 52W High

$23.98

+47.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%